Naitik Jain

发表

Tumor-promoting aftermath post-chemotherapy: A focus on breast cancer.

S. B. Singh, R. Raghuvanshi, Saurabh Shah, 2022, Life sciences.

Immune Cell-Camouflaged Surface-Engineered Nanotherapeutics for Cancer Management.

S. B. Singh, Saurabh Shah, Paras Famta, 2022, Acta biomaterialia.

The portrayal of macrophages as tools and targets: A paradigm shift in cancer management.

D. Srinivasarao, S. B. Singh, Saurabh Shah, 2023, Life sciences.

Multifaceted applications of ulvan polysaccharides: Insights on biopharmaceutical avenues.

D. Srinivasarao, S. B. Singh, R. Raghuvanshi, 2023, International journal of biological macromolecules.

Strategic combinatorial delivery of Tranilast and Paclitaxel using differently functionalized PLGA Nanoparticles for Enhanced penetration and Accumulation in Breast Tumor

Paras Famta, Saurabh Srivastava, Shashi Bala Singh, 2022, Medical Hypotheses.

Albumin-hitchhiking: Fostering the pharmacokinetics and anticancer therapeutics.

D. Srinivasarao, S. B. Singh, A. Murthy, 2022, Journal of controlled release : official journal of the Controlled Release Society.

Integration of miRNA’s theranostic potential with nanotechnology: Promises and challenges for Parkinson’s disease therapeutics

S. B. Singh, Paras Famta, D. Khatri, 2023, Mechanisms of Ageing and Development.

Quality by design (QbD) abetted development of pioglitazone incorporated liposomes-loaded hyaluronic acid-based in situ hydrogel for the management of melanoma

S. B. Singh, Saurabh Shah, Paras Famta, 2023, Journal of Drug Delivery Science and Technology.

Aptamer guided nanomedicine strategies in prostate cancer: Targeting and diagnosis

A. Asthana, D. Srinivasarao, S. B. Singh, 2023, Journal of Drug Delivery Science and Technology.

Unravelling the potential of microbots in cancer therapy

D. Srinivasarao, S. B. Singh, Saurabh Shah, 2023, Applied Materials Today.

Quality by design Endorsed Fabrication of Ibrutinib-loaded Human Serum Albumin Nanoparticles for the Management of Leukemia.

Nusrat M. Begum, D. Srinivasarao, S. B. Singh, 2023, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Neutrophil membrane-based nanotherapeutics: Propitious paradigm shift in the management of cancer.

D. Srinivasarao, S. B. Singh, R. Raghuvanshi, 2023, Life sciences.

Quality by design accredited self-nanoemulsifying delivery of ibrutinib for extenuating the fast-fed variability, ameliorating the anticancer activity and oral bioavailability in prostate cancer

Saurabh Shah, Paras Famta, D. Khatri, 2023, Journal of Drug Delivery Science and Technology.

Supramolecular self-assembled peptide-engineered nanofibers: A propitious proposition for cancer therapy.

P. S. Rajinikanth, R. Raghuvanshi, Saurabh Shah, 2023, International journal of biological macromolecules.

‘Nano-in-nano’ – Breaching the barriers of the tumor microenvironment using nanoparticle-incorporated nanofibers

R. Raghuvanshi, Saurabh Shah, Paras Famta, 2023, Journal of Drug Delivery Science and Technology.

Quality by design enabled tumor microenvironment-responsive simvastatin-loaded liposomes for prostate cancer management

Saurabh Shah, Paras Famta, Saurabh Srivastava, 2024, Journal of Drug Delivery Science and Technology.

Nanomedicine-RNAi interface: Architypes in prostate cancer therapeutics

Saurabh Shah, Paras Famta, Saurabh Srivastava, 2024, Journal of Drug Delivery Science and Technology.

Unravelling the role of tumor microenvironment responsive nanobiomaterials in spatiotemporal controlled drug delivery for lung cancer therapy.

Saurabh Shah, Paras Famta, Saurabh Srivastava, 2024, Drug delivery and translational research.

Nanocarrier-based drug delivery via cell-hitchhiking: Emphasizing pharmacokinetic perspective towards taming the “big-old” tumors

S. B. Singh, Saurabh Shah, Tausif Ahmed, 2023, Journal of Drug Delivery Science and Technology.